Latest read on rare disease gene therapy from Insmed CEO Will Lewis CNBC Television 11 months ago Play Download
Insmed CEO on what’s next for company after FDA greenlights lung disease drug CNBC Television 1 year ago Play Download
Insmed (INSM) Stock Analysis: The BRINSUPRI Effect & Path to Profitability Global news Report 1 month ago Play Download
Insmed CEO Will Lewis talks its rare disease drug pipeline CNBC Television 9 months ago Play Download
Insmed Inc (INSM): 🫁 The $14B Sovereign Monopoly Over Rare Lung Disease Griffonomics 1 month ago Play Download
Insmed (INSM): 17.9 months of runway at current burn Mixinum Financial Review 2 weeks ago Play Download
Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news CNBC Television 10 months ago Play Download